Ligand Binding and Activation of PPAR γ by Firemaster ® 550: Effects on Adipogenesis and Osteogenesis in Vitro
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The use of alternative flame retardants has increased since the phase out of pentabromodiphenyl ethers (pentaBDEs). One alternative, Firemaster® 550 (FM550), induces obesity in rats. Triphenyl phosphate (TPP), a component of FM550, has a structure similar to that of organotins, which are obesogenic in rodents. OBJECTIVES: We tested the hypothesis that components of FM550 are biologically active peroxisome proliferator-activated receptor γ (PPARγ) ligands and estimated indoor exposure to TPP. METHODS: FM550 and its components were assessed for ligand binding to and activation of human PPARγ. Solvent mapping was used to model TPP in the PPARγ binding site. Adipocyte and osteoblast differentiation were assessed in bone marrow multipotent mesenchymal stromal cell models. We estimated exposure of children to TPP using a screening-level indoor exposure model and house dust concentrations determined previously. RESULTS: FM550 bound human PPARγ, and binding appeared to be driven primarily by TPP. Solvent mapping revealed that TPP interacted with binding hot spots within the PPARγ ligand binding domain. FM550 and its organophosphate components increased human PPARγ1 transcriptional activity in a Cos7 reporter assay and induced lipid accumulation and perilipin protein expression in BMS2 cells. FM550 and TPP diverted osteogenic differentiation toward adipogenesis in primary mouse bone marrow cultures. Our estimates suggest that dust ingestion is the major route of exposure of children to TPP. CONCLUSIONS: Our findings suggest that FM550 components bind and activate PPARγ. In addition, in vitro exposure initiated adipocyte differentiation and antagonized osteogenesis. TPP likely is a major contributor to these biological actions. Given that TPP is ubiquitous in house dust, further studies are warranted to investigate the health effects of FM550.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412 · cited 1×
“Grun et al. (2006) suggested that exposure to environmental obesogens may play a role in the obesity epidemic.”
BackgroundA new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Pfaffl MW. 2001.”
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181 · cited 5×
“Activation of PPARγ by FM550 and TPP was reflected in the significantly increased mRNA expression of Fabp4, a PPARγ-target gene (Tontonoz et al. 1994) (Figure 5B).”
InfluentialFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 956 · cited 1×
“Osteoporosis has been referred to as “obesity of the bone” (Rosen and Bouxsein 2006).”
BackgroundPPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.-I., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19900 · Cited by 869
Semivolatile organic compounds in indoor environments
Weschler, C. J., & Nazaroff, W. W. (2008) · Atmospheric Environment · doi:10.1016/j.atmosenv.2008.09.052 · Cited by 850
Greenberg, A. S., Egan, J. J., Wek, S. A., Garty, N. B., Blanchette-Mackie, E. J., & Londos, C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99168-4 · Cited by 832
Detection of Organophosphate Flame Retardants in Furniture Foam and U.S. House Dust
Stapleton, H. M., Klosterhaus, S., Eagle, S., Fuh, J., Meeker, J. D., Blum, A., & Webster, T. F. (2009) · Environmental Science & Technology · doi:10.1021/es9014019 · Cited by 766
Self-citationADD1/SREBP1 activates PPARγ through the production of endogenous ligand
Kim, J. B., Wright, H. M., Wright, M., & Spiegelman, B. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4333 · Cited by 669 · cited 2×
“…by V.K. Chatterjee, University of Cambridge, Cambridge, UK) (Gurnell et al. 2000) and human RXRA (plasmid 8882; Addgene, Cambridge, MA) (Tontonoz et al. 1994), with PPRE x3-TKluc (plasmid 1015; Addgene) (Kim et al. 1998) and CMV-eGFP reporter constructs using Lipofectamine2000 (Invitrogen).”
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., Gardiner, D. M., Kanno, J., Iguchi, T., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0367 · Cited by 612 · cited 9×
“These obesogens are agonists of peroxisome proliferator activated receptor γ (PPARγ) (Feige et al. 2007; Grun et al. 2006), a nuclear receptor and master regulator of adipogenesis (Tontonoz and Spiegelman 2008).”
InfluentialVolume and Frequency of Breastfeedings and Fat Content of Breast Milk Throughout the Day
Kent, J. C., Mitoulas, L. R., Cregan, M. D., Ramsay, D. T., Doherty, D. A., & Hartmann, P. E. (2006) · Pediatrics · doi:10.1542/peds.2005-1417 · Cited by 537 · cited 1×
“For comparison, a molar concentration of OPFRs of 0.1 μM can be estimated by assuming a concentration of 41 g lipid/L milk (Kent et al. 2006) and an average OPFR molecular weight of 300 g/mol (the molecular weight of TPP is 326 g/mol).”
InfluentialAlternate and New Brominated Flame Retardants Detected in U.S. House Dust
Stapleton, H. M., Allen, J. G., Kelly, S. M., Konstantinov, A., Klosterhaus, S., Watkins, D., McClean, M. D., & Webster, T. F. (2008) · Environmental Science & Technology · doi:10.1021/es801070p · Cited by 531
Self-citationDodson, R. E., Perovich, L. J., Covaci, A., Van den Eede, N., Ionas, A. C., Dirtu, A. C., Brody, J. G., & Rudel, R. A. (2012) · Environmental Science & Technology · doi:10.1021/es303879n · Cited by 530
Brenke, R., Kozakov, D., Chuang, G.-Y., Beglov, D., Hall, D., Landon, M. R., Mattos, C., & Vajda, S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp036 · Cited by 455 · cited 3×
“We determined binding hot spots in the PPARγ LBD using the computational solvent mapping algorithm FTMap (Brenke et al. 2009).”
Self-citationBone Is a Target for the Antidiabetic Compound Rosiglitazone
Rzonca, S. O., Suva, L. J., Gaddy, D., Montague, D. C., & Lecka-Czernik, B. (2004) · Endocrinology · doi:10.1210/en.2003-0746 · Cited by 454 · cited 1×
“Accordingly, treatment with the therapeutic PPARγ ligand rosiglitazone, either in vivo or in in vitro bone marrow MSC models, results in increased expression and activity of PPARγ and a concomitant decrease in Runx2 expression and activity (Ali et al. 2005; Rzonca et al. 2004).”
BackgroundNovel and High Volume Use Flame Retardants in US Couches Reflective of the 2005 PentaBDE Phase Out
Stapleton, H. M., Sharma, S., Getzinger, G., Ferguson, P. L., Gabriel, M., Webster, T. F., & Blum, A. (2012) · Environmental Science & Technology · doi:10.1021/es303471d · Cited by 446 · cited 2×
“Although we previously measured C0 for TPP in furniture foam (Stapleton et al. 2012), there is no generally accepted way to estimate y0 from C0 for SVOCs (Little et al.”
MethodSelf-citationRosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2004-0735 · Cited by 444 · cited 1×
“Accordingly, treatment with the therapeutic PPARγ ligand rosiglitazone, either in vivo or in in vitro bone marrow MSC models, results in increased expression and activity of PPARγ and a concomitant decrease in Runx2 expression and activity (Ali et al. 2005; Rzonca et al. 2004).”
BackgroundVan den Eede, N., Dirtu, A. C., Neels, H., & Covaci, A. (2011) · Environment International · doi:10.1016/j.envint.2010.11.010 · Cited by 442
Partial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
Bruning, J. B., Chalmers, M. J., Prasad, S., Busby, S. A., Kamenecka, T. M., He, Y., Nettles, K. W., & Griffin, P. R. (2007) · Structure · doi:10.1016/j.str.2007.07.014 · Cited by 389
Kojima, H., Takeuchi, S., Itoh, T., Iida, M., Kobayashi, S., & Yoshida, T. (2013) · Toxicology · doi:10.1016/j.tox.2013.09.004 · Cited by 365 · cited 2×
“…nuclear receptors, activating constitutive androstane receptor, pregnane X receptor, and estrogen receptor–mediated reporter activity and antago nizing androgen, progesterone, and glucocorticoid receptor– mediated reporter activity (Honkakoski et al. 2004; Kojima et al. 2013; Suzuki et al. 2013).”
BackgroundFeige, J. N., Gelman, L., Rossi, D., Zoete, V., Métivier, R., Tudor, C., Anghel, S. I., Grosdidier, A., Lathion, C., Engelborghs, Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702724200 · Cited by 356 · cited 1×
“These obeso gens are agonists of peroxisome proliferator-activated receptor γ (PPARγ) (Feige et al. 2007; Grun et al. 2006), a nuclear receptor and master regulator of adipogenesis (Tontonoz and Spiegelman 2008).”
Meeker, J. D., Cooper, E. M., Stapleton, H. M., & Hauser, R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205907 · Cited by 322 · cited 3×
“Meeker et al. (2013) reported no significant association between diphenyl phosphate in urine of adult males and TPP in dust from their homes.”
BackgroundInfluentialSelf-citationPatisaul, H. B., Roberts, S. C., Mabrey, N., McCaffrey, K. A., Gear, R. B., Braun, J., Belcher, S. M., & Stapleton, H. M. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21439 · Cited by 265 · cited 5×
“For comparison, Patisaul et al. (2013) exposed dams to 0.1 and 1 mg/day FM550, or approximately 0.25–2.5 mg/kg BW/day, of which TPP represented approximately 10–20%.”
BackgroundInfluentialSelf-citationGurnell, M., Wentworth, J. M., Agostini, M., Adams, M., Collingwood, T. N., Provenzano, C., Browne, P. O., Rajanayagam, O., Burris, T. P., Schwabe, J. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5754 · Cited by 264 · cited 3×
“Cos-7 cells were transiently transfected with vectors containing human PPARG1 (provided by V.K. Chatterjee, University of Cambridge, Cambridge, UK) (Gurnell et al. 2000) and human RXRA (plasmid 8882; Addgene, Cambridge, MA) (Tontonoz et al. 1994), with PPRE x3-TKluc (plasmid 1015; Addgene) (Kim et al. 1998) and CMV-eG…”
Organophosphorus flame retardants (PFRs) in human breast milk from several Asian countries
Kim, J.-W., Isobe, T., Muto, M., Tue, N. M., Katsura, K., Malarvannan, G., Sudaryanto, A., Chang, K.-H., Prudente, M., Viet, P. H., et al. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.02.033 · Cited by 246 · cited 2×
“Analyses of OPFRs in human milk have shown that TPP is a common contaminant and that levels of total OPFRs can reach 600 ng/g lipid (Kim et al. 2014).”
BackgroundStructural conservation of druggable hot spots in protein–protein interfaces
Kozakov, D., Hall, D. R., Chuang, G.-Y., Cencic, R., Brenke, R., Grove, L. E., Beglov, D., Pelletier, J., Whitty, A., & Vajda, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101835108 · Cited by 243 · cited 1×
“The poses were ranked on the basis of this overlap measure, and the pose with the best overlap was selected as the most likely binding mode (Kozakov et al. 2011) (for a detailed description of this analysis, see Supplemental Material, “Computational analysis of ligand binding to PPARγ”).”
Self-citationLittle, J. C., Weschler, C. J., Nazaroff, W. W., Liu, Z., & Cohen Hubal, E. A. (2012) · Environmental Science & Technology · doi:10.1021/es301088a · Cited by 227 · cited 14×
“where h is the convective mass transfer coefficient over the emission surface, A is the surface area of the source (assumed to be poly urethane foam with an additive flame retardant), Q* is the equivalent ventilation rate adjusted for particulate-bound SVOCs, and Kdust is the dust/vapor partition coefficient (Little e…”
BackgroundMethodInfluentialPredictors of tris(1,3-dichloro-2-propyl) phosphate metabolite in the urine of office workers
Carignan, C. C., McClean, M. D., Cooper, E. M., Watkins, D. J., Fraser, A. J., Heiger-Bernays, W., Stapleton, H. M., & Webster, T. F. (2013) · Environment International · doi:10.1016/j.envint.2013.02.004 · Cited by 172
Self-citationCooper, E. M., Covaci, A., van Nuijs, A. L. N., Webster, T. F., & Stapleton, H. M. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5294-7 · Cited by 170
Self-citationFeige, J. N., Gerber, A., Casals-Casas, C., Yang, Q., Winkler, C., Bedu, E., Bueno, M., Gelman, L., Auwerx, J., Gonzalez, F. J., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901217 · Cited by 148 · cited 3×
“FM550 is composed of bis-(2-ethylhexyl) tetrabromophthalate (TBPH), a brominated analogue of bis-(2-ethylhexyl) phthalate that is a known obesogen (Feige et al. 2010), tetrabromobenzoate (TBB), and a mixture of triaryl phosphates including triphenyl phosphate (TPP) and several isomers of mono-, di- and triisopropylate…”
Pietrangeli, C. E., Hayashi, S., & Kincade, P. W. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180606 · Cited by 145 · cited 2×
“BMS2 cells are C57BL/6 mouse–derived bone marrow stromal cells (provided by P. Kincade, Oklahoma Medical Research Foundation, Oklahoma City, OK) (Pietrangeli et al. 1988).”
BackgroundSuzuki, G., Tue, N. M., Malarvannan, G., Sudaryanto, A., Takahashi, S. I., Tanabe, S., Sakai, S.-I., Brouwer, A., Uramaru, N., Kitamura, S., et al. (2013) · Environmental Science & Technology · doi:10.1021/es304691a · Cited by 115 · cited 1×
“…nuclear receptors, activating constitutive androstane receptor, pregnane X receptor, and estrogen receptor–mediated reporter activity and antago nizing androgen, progesterone, and glucocorticoid receptor– mediated reporter activity (Honkakoski et al. 2004; Kojima et al. 2013; Suzuki et al. 2013).”
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice
Carmona, M. C., Louche, K., Nibbelink, M. M., Prunet‐Marcassus, B., Bross, A., Desbazeille, M., Dacquet, C., Renard, P., Casteilla, L., & Pénicaud, L. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802943 · Cited by 89
Sheu, S., Kaya, T., Waxman, D. J., & Vajda, S. (2004) · Biochemistry · doi:10.1021/bi048032c · Cited by 87 · cited 1×
“In a previous study, the FTMap solvent mapping program (Brenke et al. 2009) was used to identify two main ligand binding regions within PPARγ’s large binding site (Sheu et al. 2005).”
Self-citationSpringer, C., Dere, E., Hall, S. J., McDonnell, E. V., Roberts, S. C., Butt, C. M., Stapleton, H. M., Watkins, D. J., McClean, M. D., Webster, T. F., et al. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1204932 · Cited by 87
Self-citationEffects of triaryl phosphates on mouse and human nuclear receptors
Honkakoski, P., Palvimo, J. J., Penttilä, L., Vepsäläinen, J., & Auriola, S. O. K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.037 · Cited by 80 · cited 1×
“Interestingly, TPP has been shown to interact with a variety of nuclear receptors, activating constitutive androstane receptor, pregnane X receptor, and estrogen receptor–mediated reporter activity and antago nizing androgen, progesterone, and glucocorticoid receptor– mediated reporter activity (Honkakoski et al. 2004…”
BackgroundYanik, S. C., Baker, A. H., Mann, K. K., & Schlezinger, J. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr140 · Cited by 76 · cited 1×
“Lipid accumulation was quantified in bone marrow cultures and BMS2 cells by Nile red staining (Yanik et al. 2011).”
Self-citationHot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery
Hall, D. R., Ngan, C. H., Zerbe, B. S., Kozakov, D., & Vajda, S. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200468p · Cited by 58 · cited 1×
“Ligands that bind to a site generally overlap well with binding hot spots (Hall et al. 2012); therefore, on the basis of our results, we are convinced that TPP binds to PPARγ in a manner very similar to the binding of selective partial agonists.”
BackgroundSelf-citation
Cited by
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
“Other studies have identified BPA [132, 420, 421], bisphenol A diglycidyl ether [422], aklylphenols [423], phthalates [356, 357, 372, 424, 425] and flame retardants [372, 424, 426, 427] as well as organochlorine [428, 429] and neonicotinoid pesticides [430] as chemicals that can promote adipocyte differentiation.”
Endocrine disruptors and obesity
Heindel, J. J., Newbold, R., & Schug, T. T. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.163 · Cited by 451
Mechanisms of flame retardant toxicity and their impacts on anxiety and cognition in the brain
Rojas, C. M., Wiersielis, K. R., & Roepke, T. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf074 · Cited by 10
Metadata
- Authors
- Pillai, H. K., Fang, M., Beglov, D., Kozakov, D., Vajda, S., Stapleton, H. M., Webster, T. F., & Schlezinger, J. J.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-11
- Volume
- 122
- Issue
- 11
- Pages
- 1225-1232
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2147881974
- Cited by
- 199
- References
- 41
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.